Skip to main content
. 2021 Jan 15;23(1):e26089. doi: 10.2196/26089

Table 1.

Topics related to the COVID-19 vaccine, with metadata on topic name, reading quantity, and date.

Topic name Readers (million), n Date
#COVID-19 vaccine could be available in early 2021# 820 February 9
#Wei Chen’s Team conducts the Phase I clinical trial of COVID-19 vaccine# 243.8 March 20
#When will the COVID-19 vaccine be available# 50.9 April 14
#China’s COVID-19 vaccine has entered Phase II clinical trial# 33 April 14
#The first participant of the COVID-19 vaccine has not yet shown adverse reactions# 21 April 14
#The world’s first COVID-19 inactivated vaccine# 41.2 April 19
#What is the COVID-19 inactivated vaccine# 25.2 April 21
#Chinese first COVID-19 inactivated vaccine entered Phase II clinical trial# 4566.4 April 24
#Phase I clinical trial of the first Chinese COVID-19 vaccine has good results# 934.5 May 22
#The safety and effectiveness of the COVID-19 inactivated vaccine have been verified# 76.9 May 29
#More than 2000 people received the COVID-19 inactivated vaccine injection# 479.6 May 30
#COVID-19 inactivated vaccine is expected to be available at the end of this year or early next year# 162.1 May 30
#China developed another kind of COVID-19 inactivated vaccine# 2000 June 9
#World’s first COVID-19 inactivated vaccine participant produces antibodies# 39.4 June 17
#Chinese COVID-19 vaccine will be launched as early as 2021# 37.9 June 18
#CNBG’s COVID-19 inactivated vaccine is not affected by virus mutation# 1276.2 June 19
#Chinese three COVID-19 vaccines complete Phase II clinical trials# 18,000 June 20
#Domestic COVID-19 inactivated vaccine launches international clinical phase Ⅲ trial# 84.2 June 23
#COVID-19 inactivated vaccine production workshop is completed in Wuhan# 7388.4 July 2
#WHO requires the protection period of the COVID-19 vaccine to be at least six months# 56.8 July 3
#Chinese COVID-19 vaccine Phase 2 clinical trial achieves good results# 131 July 21
#COVID-19 vaccine may be available at the end of the year# 345.4 July 22
#World first officially releases Phase II clinical data of COVID-19# 238.3 July 23
#The price of the COVID-19 vaccine will not exceed $40# 888.9 July 29
#Russian COVID-19 vaccine will be free of charge# 20,000 August 1
#The first COVID-19 inactivated vaccine workshop passed safety inspection# 44.9 August 5
#Beijing COVID-19 inactivated vaccine production workshop can be put into production at any time# 45.5 August 5
#Half of the COVID-19 vaccines in Phase III clinical trials come from China# 150.6 August 7
#Gates required the COVID-19 vaccine to be priced below $3# 963.7 August 8
#Research Institute refutes rumors of COVID-19 vaccine 498 yuan an injection# 127.4 August 13
#COVID-19 vaccine not yet be available# 3 August 13
#COVID-19 inactivated vaccine two injections less than one thousand yuan# 3081.6 August 18
#Domestic COVID-19 inactivated vaccine is expected to be available at the end of December# 131.6 August 18
#Russian second COVID-19 vaccine starts Phase 2 clinical trial# 70.1 August 18
#COVID-19 vaccine two injections 1000 yuan is too expensive# 24.2 August 19
#The price of COVID-19 vaccine can only be based on cost# 17,000 August 23
#How to price the COVID-19 vaccine# 254.2 August 23
#CNBG declared COVID-19 vaccine is likely to be available at the end of this year# 354.6 August 23
#National Health Commission claimed that the price of COVID-19 vaccine was lower than two injections of 1,000 yuan# 65.9 August 23
#Domestic COVID-19 inactivated vaccine first appears# 19,000 September 5
#Domestic COVID-19 inactivated vaccine appears in CIFTIS# 5766.4 September 6
#The COVID-19 vaccine will be priced based on factors such as consumers’ ability to pay# 134.5 September 7
#Domestic COVID-19 inactivated vaccine inoculates hundreds of thousands of people with zero infection# 2102.4 September 11
#Oxford vaccine volunteers have side effects# 769.1 September 9
#The COVID-19 vaccine produced by Pfizer in America has side effects# 17,000 September 16
#The COVID-19 inactivated vaccine is expected to be available at the end of the year# 4319.2 September 8
#The COVID-19 vaccine price in China will be within the scope of public acceptance# 11,000 September 2
#The COVID-19 inactivated vaccine is only one kilometer away from success# 23,000 September 2
#Two injections 600 yuan for domestic COVID-19 vaccine # 7737 September 3
#The price of domestic COVID-19 vaccine is released# 4413.4 September 2
#Four COVID-19 vaccines in China enter Phase III clinical trials# 428.6 September 2
#China formally joins COVAX# 23,000 October 9